Gratus Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Gratus Capital's ASND Position: Q2 2024 in Review
Gratus Capital held its Ascendis Pharma (ASND) position steady in Q2 2024 at 5,000 shares worth $682K. The position accounts for 0.03% of the portfolio, ranked #220.
Gratus Capital first reported a position in ASND in Q1 2023 and has held it in 6 quarters since. The position peaked at $756K in Q1 2024. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.
- Gratus Capital held 5,000 shares of Ascendis Pharma worth $682K as of Q2 2024.
- Gratus Capital left its Ascendis Pharma share count unchanged in Q2 2024.
- Ascendis Pharma made up 0.03% of Gratus Capital's portfolio in Q2 2024, its #220 holding.
- Gratus Capital first reported a position in Ascendis Pharma in Q1 2023 and has held it in 6 quarters since.
- Gratus Capital's Ascendis Pharma position peaked at $756K in Q1 2024.
- 203 funds tracked by Wall St. Rank held Ascendis Pharma as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.